Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
16,029
Total Claims
$1.8M
Drug Cost
643
Beneficiaries
$2,749
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+145%
Opioid rate vs peers
5.5% vs 2.2% avg
+95%
Cost per patient vs peers
$2,749 vs $1,411 avg
+71%
Brand preference vs peers
18.2% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
5.5%
Opioid Rate
878
Opioid Claims
$23K
Opioid Cost
4.2%
Long-Acting Rate
Brand vs Generic
Brand: 2,891 claims · $1.5M
Generic: 13,024 claims · $269K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Tirzepatide | 175 | $202K |
| Apixaban | 423 | $192K |
| Semaglutide | 109 | $112K |
| Apremilast | 18 | $90K |
| Dulaglutide | 81 | $88K |
| Dapagliflozin Propanediol | 122 | $72K |
| Budesonide/Glycopyr/Formoterol | 89 | $60K |
| Semaglutide | 39 | $51K |
| Rivaroxaban | 95 | $49K |
| Insulin Lispro | 26 | $40K |
| Insulin Glargine,hum.Rec.Anlog | 85 | $35K |
| Budesonide/Formoterol Fumarate | 61 | $30K |
| Mirabegron | 76 | $30K |
| Fluticasone Propion/Salmeterol | 63 | $28K |
| Empagliflozin | 43 | $28K |
Prescribing Profile
Patient Profile
72
Avg Age
56%
Female
1.58
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About